Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 925 | 608 | 1,051 | 1,076 | 836 |
| Cost of Goods | 241 | 1,137 | 385 | 287 | 350 |
| Gross Profit | 684 | -529 | 666 | 789 | 486 |
| Operating Expenses | 4,751 | 7,132 | 5,045 | 5,432 | 5,936 |
| Operating Income | -3,826 | -7,525 | -3,994 | -4,356 | -5,100 |
| Interest Expense | 177 | 187 | 197 | 189 | 1,650 |
| Other Income | 4,551 | 4,894 | 518 | 300 | 0 |
| Pre-tax Income | 548 | -2,818 | -3,673 | -4,245 | -6,750 |
| Net Income Continuous | 548 | -2,818 | -3,673 | -4,245 | -6,750 |
| Net Income | $548 | $-2,818 | $-3,673 | $-4,245 | $-6,750 |
| EPS Basic Total Ops | 8,490.00 | -950.00 | -3,572.00 | -7,030.00 | 171,060.00 |
| EPS Basic Continuous Ops | 8,490.60 | -950.32 | -3,571.55 | -7,029.96 | 170,974.70 |
| EPS Diluted Total Ops | 8,490.00 | -950.00 | -3,572.00 | -7,030.00 | 171,060.00 |
| EPS Diluted Continuous Ops | 8,490.60 | -950.32 | -3,571.55 | -7,029.96 | 170,974.70 |
| EBITDA(a) | $-3,210 | $-6,864 | $-3,332 | $-3,703 | $-3,000 |